ARTICLE | Company News
Karo Bio, Novalon deal
May 15, 2000 7:00 AM UTC
KARO completed its previously announced acquisition of Novalon in a stock transaction (see BioCentury, April 3). Novalon is developing BioKeys, small proteins that bind to protein targets such as nucl...